| General Information |
| Business: |
(Incorporated in the Cayman Islands)
We intend to focus our search for business combination targets in the pharmaceutical industry.
(Note: Drugs Made in America Acquisition Corp. II priced its IPO in sync with the terms in the prospectus – 50 million units at $10.00 each – to raise $500 million on Wednesday night, Sept. 24, 2025. Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. Background: Drugs Made in America Acquisition Corp. II filed its S-1 for its SPAC IPO on July 18, 2025, and disclosed the terms: 50.0 million units at $10.00 each to raise $500.0 million.)
|
| Industry: |
BLANK CHECKS |
| Employees: |
0 |
| Founded: |
2024 |
| Contact Information |
| Address |
1 East Broward Boulevard, Suite 700 Fort Lauderdale, FL 33301 (954) 870-3099 |
| Phone Number |
(954) 870-3099 |
| Web Address |
|
| View Prospectus: |
Drugs Made in America Acquisition Corp. II |
| Financial Information |
| Market Cap |
$637.0mil |
| Revenues |
$0 mil (last 12 months) |
| Net Income |
$0 mil (last 12 months) |
| IPO Profile |
| Symbol |
DMIIU |
| Exchange |
NASDAQ |
| Shares (millions): |
50.0 |
| Price range |
$10.00 - $10.00 |
| Est. $ Volume |
$500.0 mil |
| Manager / Joint Managers |
Cantor |
| CO-Managers |
|
| Expected To Trade: |
9/25/2025 |
|
Status:
|
Priced |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
